CSF2 and multiple sclerosis: Thus, the ability of Gas6 to suppress GM-CSF induction over a prolonged period could provide a novel avenue to therapeutically target GM-CSF in disorders such as multiple sclerosis, where GM-CSF plays a critical role in mediating the disease pathology [49].